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| INTRODUCTION
Unfractioned heparin (UFH) and its low molecular weight derivatives (LMWH) are widely used for the prevention and the treatment of venous thromboembolic events (Gray, Hogwood, & Mulloy, 2012) . Heparins are heterogeneous glycosaminoglycans composed of a mixture of polysulfated chains comprised of alternating disaccharide residues of D-glucosamine and uronic acid residues linked by glycosidic bonds. Low molecular weight heparins (2-8 kDa) are issued from UFH (14 kDa) by chemical or enzymatic depolymerisation and possess different anticoagulant properties. In addition to their different polysaccharide size distribution, the structural variations could explain the different anticoagulant profiles of LMWH. These molecules show considerable variations in their pharmacokinetic and pharmacodynamic effect, arguing in favour of noninterchangeability of LMWH as recommended by the Food and Drug Administration (Fareed et al., 2004) . In addition to these anticoagulant properties, LMWHs display numerous other biological activities such as anti-inflammatory, antiangiogenic or antimetastatic properties (Yan et al., 2017) .
UFH and derivatives are mainly excreted by the kidney.
Numerous studies have been performed in chronic kidney disease (CKD) patients, allowing the establishment of specific posology and LMWH choice as a function of kidney filtration capacity (Sciascia et al., 2017) . UFH is able to limit glomerular function deficiency in glomerulonephritis through multiple mechanisms involving an effect on growth factors, an inhibition of heparinase, or by attenuating the inflammatory status (Gambaro & Kong, renoprotective effects of heparins, little is known about their effects on healthy kidney. In vitro studies have demonstrated that heparin could enhance specific gene expression in isolated rat podocytes (Yaoita et al., 2014) ; but up to now, there is no functional study analysing the effects of UFH or LMWH on the human kidney. The constant development of new pharmacological compounds, and in particular heparin derivatives, needs functional tests to be able to predict their effects on kidney function (Tiong et al., 2014) .
Kidney glomerular filtration involves endothelial cells, glomerular basement membrane, and podocytes. Podocytes are terminally differentiated epithelial cells that display elongated interdigitating foot processes that form a zipper-like network allowing filtration.
Specific interactions between cells, named slit diaphragms, form the ultimate filtration barrier which prevent the passage of macromolecules larger than serum albumin (Garg, 2018) . Among the numerous proteins that are involved in the slit diaphragm, nephrin and ZO-1 play an important role in the maintenance of this particular structure.
Besides these specialised intercellular complexes, podocytes must efficiently adhere to the basal membrane. At a molecular level, cellmatrix interactions involve podocyte adhesion receptors, such as integrins (and notably the main integrin α3β1), that are intimately coupled to cell cytoskeleton (Sever & Schiffer, 2018) . This podocyte spatial organisation is crucial for the maintenance of an efficient glomerular filtration. These properties identify the podocyte as a "weak link" in numerous pathologies such as diabetes mellitus (Dai, Liu, & Liu, 2017) , lupus nephritis (Chen & Hu, 2017) or focal segmental glomerulosclerosis (FSG), as well as a sensitive target for potential nephrotoxic drugs.
Based on these considerations and previous results, we studied the effects of commercially available UFH and LMWH on podocytes.
Considering that the podocyte is a sensitive target cell involved in glomerular filtration, we focused on this cell using an in vitro assay allowing the measurement of albumin permeability through a human podocyte monolayer. The goal of this study was to investigate the effect of heparin and its derivatives on podocyte permeability by functional tests combined with morphological/phenotypic analysis after drug exposure. Our in vitro approach has also been carried out to highlight new properties of heparins regardless of their anticoagulant capacities.
| MATERIALS AND METHODS
Except when specified, all the reagents were purchased from Sigma- 
| Cell culture
Human podocytes, kindly provided by Saleem et al. (2002) , were routinely cultured in RPMI-1640 medium containing 10% foetal bovine serum, 1% insulin-transferrin-selenium-A supplement, and 1% penicillin-streptomycin solution as previously described (Delézay et al., 2017 
| Evaluation of podocyte monolayer permeability
The experiments were performed on differentiated podocytes grown on permeable supports (BD-Falcon cell culture inserts, 24-well size, 3-μm pore size) treated or not for 48 hr with increasing concentrations of UFH, enoxaparin, tinzaparin, fondaparinux, argatroban, rivaroxaban or dabigatran in the two compartments (apical and basal). Each assay was performed in quadruplicate (n = 4) with a positive control (puromycin aminonucleoside [PAN], 40 µg/ml) to verify podocyte response to drug injury. Podocyte monolayer permeability was determined in the basal to apical direction.
Cells were first incubated for 1 hr at 37°C in serum-free RPMI medium (SF-RPMI) and then incubated with fluorescein isothiocyanate-bovine serum albumin (FITC-BSA) at a concentration of 0.5 g/L in the basal compartment (1 ml). After an incubation of 4 hr at 37°C, 100 μl was taken from the apical compartment, transferred into a 96-well plate and fluorescence was measured using a fluorimeter (Exc = 485 nm, Em = 538 nm; Fluoroskan Ascent; Thermo Fisher Scientific, Dardilly, France).
The apparent permeability of albumin was calculated with the following formula:
where P app is the apparent permeability, V r is the volume of medium solution in the receiving chamber, C 0 is the initial concentration of drug in the basal compartment, S is the area of the monolayer, C 2 is the concentration of the drug found in the apical compartment after an incubation of 4 hr, and t is the incubation time.
| Morphological/phenotypic analysis by immunofluorescence experiments
Immunofluorescence experiments were performed with phalloidin- For the quantitative analysis of cellular parameters, 12 images (three images by well, four wells for each condition) were captured and analysed using the ImageJ software (Rueden et al. 2017 ) using a protocole adapted from the article by Kachurina et al. (2016) .
Briefly, the cell number was determined by counting Hoechst 33342-labelled cell nucleus (blue channel) using the "analyse particles" function on ImageJ software after an automatic threshold (default). For the quantification of the total cell surface, the scale was converted in µm (using the scale bar) and a bandpass filter was applied on each image (green channel) to homogenise the fluorescent labelling. The same automatic threshold (MinError) was applied on each picture allowing the measurement of the total cell surface using the appropriate ImageJ software function (area measurement). The value obtained for each image was divided by the number of cells counted in the same field observed to obtain an average individual cell surface. 
| Cell detachment assay

| Flow cytometry experiments
Cell cycle analyses were performed on undifferentiated or differ- 
| Evaluation of modulation of protein expression by cell-based immunoassay
Immunodetection of the proteins involved in cell-matrix interactions were performed with antibodies directed against CD29 (integrin β1;
Bio-Rad, Marnes-la-Coquette, France), CD49c (integrin α3; Bio-Rad), 
| Statistical analysis
All results are expressed as means ± standard deviations (SD). Results were compared using the nonparametric Mann-Whitney test. A p < 0.05 (*) was considered statistically significant.
3 | RESULTS
| Effect of heparin and LMWH on podocyte monolayer permeability
Initial experiments were done to analyse the effect of heparin, enoxaparin, tinzaparin and fondaparinux on podocyte monolayer permeability to fluorescent albumin. As shown in Figure 1a , heparin was able to enhance the apparent permeability of albumin. The effect was significant from a concentration of 50 UI/ml (p < 0.05) and the permeability increased with heparin concentration. The apparent permeability obtained with the highest concentration (400 UI/ml) was in the same order as the value obtained with the nephrotoxic drug PAN (Figure 1e ). Similar data were obtained with enoxaparin F I G U R E 1 Effect of unfractionated heparin and low molecular heparin derivatives on podocyte permeability to albumin. Differentiated podocytes grown on permeable supports were incubated with increasing concentrations of unfractionated heparin (a), enoxaparin (b), tinzaparin (c) or fondaparinux (d) for 48 hr before being tested for albumin permeability. The nephrotoxic drug puromycin aminonucleoside (PAN, 40 µg/ml) was used as a positive control of podocyte perturbation (e). The results are expressed as a mean ± SD of four independent assays. Statistically significant differences between untreated cells and treated cells are calculated using the nonparametric Mann-Whitney test (*p < 0.05). BSA: bovine serum albumin (Figure 1b ), but the effect was significant only from a concentration of 200 UI/ml (p < 0.05). Similarly, an increase in enoxaparin concentration was associated with an increase of albumin permeability. In contrast to these results, tinzaparin (Figure 1c ), fondaparinux (Figure 1d ), used in similar conditions, were unable to modulate albumin permeability, suggesting relative specificity of this effect.
One should note that whatever the concentration used, no cell toxicity could be observed using XTT and LDH assays (Supporting Information Figure S1 ).
| Effect of direct oral anticoagulants on podocyte permeability to albumin
Similar experiments were done with direct oral anticoagulants to check if the effect observed could be related to the anticoagulant properties of the compounds. After 48 hr of drug exposure, the permeability to albumin was evaluated. The results, presented in Figure S1 ).
| Analysis of morphological changes
Immunofluorescent experiments were then performed to analyse potential cellular morphological changes after drug treatment. As shown in Figure 3 , the treatment of cells with UFH ( Figure 3b ) was associated with a significant decrease in cell spreading (with the presence of "hole areas") compared with the control cells (untreated; Figure 3a ). The relatively homogeneous monolayer observed with | 5 significant differences between untreated or UFH treated cells. In contrast, the surface of the cell monolayer and the surface of individual cell were significantly lower (p < 0.005) for UFH treated cells compared with untreated cells. This result indicated that UFH treatment caused a "cell narrowing." Similar quantifications were performed on PAN treated cells. This drug, used as a positive control for monolayer disturbance, was associated, as expected, with a significant (p < 0.0001) decrease of the cell number compared with untreated cells confirming the ability of this drug to promote podocyte detachment. Accordingly, the total surface covered by the cells was diminished. However, the individual cell surface was also significantly decreased (p < 0.0001) indicating that the entire cell surface decrease was not only he fact of cell loss but also due to a narrowing of the individual cell surface.
In another experiment, the assessment of cellular detachment was performed on PAN, UFH, enoxaparin and tinzaparin treated cells (Supporting Information Figure S2 ). In contrast to the results mentioned above, heparin treatment was associated with a significant cell loss compared with untreated cells (67.9 ± 17% vs. 36.5 ± 15% of detached cells for heparin and untreated cells, respectively). This result suggested that heparin weakened cell adhesion. Interestingly, enoxaparin did not affect significantly cell adhesion. The treatment with tinzaparin was quite different since this drug seemed to limit cell loss compared with untreated cells (9 ± 19% vs 36.5 ± 15%, respectively). As expected, PAN treatment generated a significant cell detachment inducing more than 79% of cell loss.
| Dedifferentiation evaluation
As previously described (Delézay et al., 2017) Figure S4 ).
| DISCUSSION
UFH and LMWH have long been used for the prevention or treatment of thrombotic events and are more recently studied for their nonanticoagulant properties such as anti-inflammatory, antiangiogenic, or antimetastatic effects (Yan et al., 2017) . These new properties offer interesting perspectives but need the evaluation of these compounds on specific target cells to explore their potential beneficial or deleterious effects. The fact that these drugs are mainly excreted by the kidney prompted us to explore their effects on podocyte, a major actor of the glomerular filtration.
We analysed the effect of UFH or LMWH on podocyte monolayer permeability by using an in vitro human podocyte model allowing a functional test combined with morphological/phenotypic analysis. In accordance with previous results (Delézay et al., 2017) , this study that are unable to modulate albumin permeability in our in vitro model.
The discrepancy observed between enoxaparin and tinzaparin effects on podocyte filtration function may be due to different manufacturing processes. Tinzaparin is the only heparin derivative that is obtained by an enzymatic digestion (heparanase); while enoxaparin is obtained after benzylation and alkaline depolymerisation of heparin. Therefore, the two drugs possess different physicochemical properties, such as a different molecular weight distribution (Bisio et al., 2015) or sulfation.
The proportion of low molecular weight polysaccharides (<2,000 Da) is greater for enoxaparin (12-20%) than for tinzaparin (<10%). These considerations could explain the differences observed in our functional test and could be compared with those obtained by Bârzu et al. (1986) on endothelial cells. In the same way, tinzaparin and enoxaparin displayed different antiangiogenic properties (Mousa, 2013) Taken together, our data indicate that UFH and enoxaparin perturb podocyte filtration property, probably by modifying the cytoskeleton and/or decreasing the expression of specific proteins involved in podocyte attachment and cell-cell interactions inducing a the decrease of the cellular spreading. This is not the case with tinzaparin. However, it is quite difficult to distinguish the chronological and the relative part of these two events in the perturbation of the podocyte permeability. Considering that glomerular filtration does not involve only podocytes but is also dependent on endothelial cells as well as a glomerular basement membrane, the evaluation of the effects of UFH and LMWH on a more complex in vitro system including these two parameters will be of particular relevance.
The intracellular mechanisms leading to podocyte injury by UFH or enoxaparin remain to be elucidated. A potential lead is the intracellular calcium path, since the podocyte cytoskeleton is highly sensitive to intracellular calcium modulations (Greka & Mundel, 2012) . This hypothesis is supported by the fact that heparin can inhibit IP3-induced Ca 2+ release (Nilsson, Zwiller, Boynton, & Berggren, 1988) and interfere with SDF-1 binding to CXCR4 (Ma et al., 2012) F I G U R E 7 Effect of (UFH or low molecular heparin derivatives on protein expression revealed by a cell-based immunoassay. Differentiated podocytes, cultured in 96-well plates, were treated or not with 200 UI/ml of UFH or enoxaparin or tinzaparin for 2 d. After the fixation and permeabilisation steps, cells were incubated with the specified antibodies that were revealed with HRP-conjugated anti-mouse antibodies and 3,3′,5,5′-tetramethylbenzidine as substrate. Optical density (absorbance) measurements were performed with a spectrophotometer (450 nm). Values reported are the mean ± SD of six independent assays. *p < 0.05, **p < 0.01, (p > 0.05). HRP: horseradish peroxidase; ns: not significant; UFH: unfractionated heparin properties of LMWH. Our in vitro system, allowing functional and morphological approaches, could be used for the screening of several drugs that can interact with the podocyte.
CONFLICTS OF INTEREST
The authors declare that there are no conflicts of interest. 
AUTHOR CONTRIBUTIONS
ORCID
Olivier Delézay
http://orcid.org/0000-0002-8308-6975
